A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

CAS IQVIA webinar in the CPhI series

Impact of COVID-19: AI and Machine Learning Solutions

As part of the CPhI webinar series, CAS and IQVIA join forces to deliver insights into optimizing Artificial Intelligence and Machine Learning for predictive analytics, clinical trials and drug discovery in response to COVID-19.

Read More

CAS COVID-19 Antiviral Candidate SAR Dataset

This open source dataset contains over 290K structure-activity relationship (SAR) data directed at COVID-19 protein, virus and disease targets reported in the literature, patents, and other public sources for over 9K of the substances included in the CAS COVID-19 Antiviral Candidate Compounds Dataset.

Read More

CAS COVID-19 Dataset Properties

The CAS Covid-19 dataset has been extracted from the CAS REGISTRY® including known anti-viral drugs and related chemical compounds that are structurally similar to known antivirals and is subject to these license terms.

Read More
CAS Logo
Press Releases

CAS applies AI-driven approach in collaboration with INPI Brazil to transform patent examinations

CAS has completed a project with The National Institute of Industrial Property (INPI) of Brazil for an enhanced examination workflow solution for chemistry patent applications using a unique blend of technology, artificial intelligence, data, and expertise. The new solution reduced application examination times by up to 50%, and helped to reduce their multi-year application backlog.

Read More